Literature DB >> 28688860

Bleeding during laparoscopic gastric bypass surgery as a risk factor for less favorable outcome. A cohort study from the Scandinavian Obesity Surgery Registry.

Erik Stenberg1, Eva Szabo2, Ingmar Näslund2, Johan Ottosson2.   

Abstract

BACKGROUND: Intraoperative adverse events are known to be associated with postoperative complications; however, little is known about whether or not blood loss during laparoscopic gastric bypass surgery affects the outcome.
OBJECTIVE: To see if intraoperative bleeding was associated with a less favorable outcome, and to identify patient-specific risk factors for intraoperative bleeding.
SETTING: Nationwide, Sweden.
METHODS: Patients who underwent laparoscopic gastric bypass surgery between January 8, 2007, and September 15, 2015, were included in the study. The volume of intraoperative blood loss was compared with data from follow-up at day 30 and 1 and 2 years after surgery. Patient-specific factors were analyzed as potential risk factors for intraoperative bleeding.
RESULTS: The study included 43,157 patients. Intraoperative bleeding was associated with an increased risk for postoperative complication (100-499 mL, odds ratio [OR] 2.97, 95% confidence interval [95%CI] 2.53-3.50;>500 mL OR 3.34, 95%CI 2.05-5.44), lower weight loss (<100 mL, 82.4±24.19% excess body mass index-loss [%EBMIL]; 100-499 mL, 76.9±24.24 %EBMIL, P<.0001;>500 mL 76.9±23.89 %EBMIL, P = .063) and lower reported quality-of-life 2 years after surgery (<100 mL, Obesity-related Problem scale (OP) 21.1±24.46; 100-499 mL, OP 25.0±26.62, P = .008;>500 mL, OP 25.2±24.46, P = .272). Diabetes (OR 1.30, 95%CI 1.08-1.58), age (OR 1.02, 95%CI 1.02-1.03), and body mass index (OR 1.03, 95%CI 1.02-1.05) were patient-specific risk factors for intraoperative bleeding≥100 mL, whereas intentional preoperative weight loss was associated with a lower risk (OR .50, 95%CI .43-.57).
CONCLUSION: Intraoperative bleeding was associated with less favorable outcome after laparoscopic gastric bypass surgery. Age, body mass index, and diabetes were risk factors for intraoperative bleeding, while preoperative weight reduction seems to be protective.
Copyright © 2017 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adverse outcome; Bariatric surgery; Bleeding; Gastric bypass; Intraoperative complication; Laparoscopic; Postoperative complication; Risk factor

Mesh:

Year:  2017        PMID: 28688860     DOI: 10.1016/j.soard.2017.05.028

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  5 in total

1.  Operative blood loss adversely affects short and long-term outcomes after colorectal cancer surgery: results of a systematic review and meta-analysis.

Authors:  C Simillis; M Charalambides; A Mavrou; T Afxentiou; M P Powar; J Wheeler; R J Davies; N S Fearnhead
Journal:  Tech Coloproctol       Date:  2022-09-22       Impact factor: 3.699

2.  Audio-video recording during laparoscopic surgery reduces irrelevant conversation between surgeons: a cohort study.

Authors:  Hannah Bergström; Lars-Göran Larsson; Erik Stenberg
Journal:  BMC Surg       Date:  2018-11-06       Impact factor: 2.102

3.  The impact of self-efficacy and health literacy on outcome after bariatric surgery in Sweden: a protocol for a prospective, longitudinal mixed-methods study.

Authors:  Maria Jaensson; Karuna Dahlberg; Ulrica Nilsson; Erik Stenberg
Journal:  BMJ Open       Date:  2019-05-09       Impact factor: 2.692

4.  Improving Hemostasis in Sleeve Gastrectomy With Alternative Stapler.

Authors:  James G Redmann; Thomas E Lavin; Matthew S French; Toby D Broussard; Maxime Lapointe-Gagner
Journal:  JSLS       Date:  2020 Oct-Dec       Impact factor: 2.172

5.  Proposition of a simple binary grading of estimated blood loss during colon surgery.

Authors:  Hugo Teixeira Farinha; David Martin; Audrey Ramó; Martin Hübner; Nicolas Demartines; Dieter Hahnloser
Journal:  Int J Colorectal Dis       Date:  2021-04-16       Impact factor: 2.571

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.